Skip to main content

Journals in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

    • The Lancet

      • ISSN: 0140-6736
      The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.
    • Respiratory Investigation

      • ISSN: 2212-5345
      Official Journal of The Japanese Respiratory SocietyRespiratory Investigation formerly known as Nihon Kokyuki Gakkaizasshi (The Journal of the Japanese Respiratory Society) is the official English - language journal of the Japanese Respiratory Society. The journal published original manuscripts on clinical investigations of a variety of respiratory diseases and medicines, along with articles concerning basic physiology, pathology, and cellular/molecular biology relating to any pulmonary diseases. Our journal is particularly interested in publishing articles that focus on the diversity of disease manifestations based on genetic and/or environmental differences between the East and West. The journal will consider peer review and publish of pediatric pulmonology, if the manuscript closely related to respiratory disease in adults. Article types accepted include Original Articles, Rapid Communications, Reviews and Guidelines, Editorials, and Letters to the editor. A case report could be exceptionally accepted only when it contains significant scientific novelty and/or important clinical relevance. The journal enthusiastically welcomes contributions not only from Japanese members of our Society but also from non-members hailing from neighboring countries in Asia and anywhere worldwide.Please prepare manuscripts in conformance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.or...
    • Nutrition

      • ISSN: 0899-9007
      The International Journal of Applied and Basic Nutritional SciencesFounded by Michael M. Meguid in the early 1980's, Nutrition presents advances in nutrition research and science, informs its readers on new and advancing technologies and data in clinical nutrition practice, encourages the application of outcomes research and meta-analyses to problems in patient-related nutrition; and seeks to help clarify and set the research, policy and practice agenda for nutrition science to enhance human well-being in the years ahead. Papers on nutrition-related plant or animal sciences are unlikely to be considered as they are outside the main focus of the Journal.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
    • Vascular Pharmacology

      • ISSN: 1537-1891
      Vascular Pharmacology is a journal of Vascular Biology and Medicine. We seek to rapidly publish transformative papers, reviews, and perspectives on vascular cells across the disciplines of biochemistry, pharmacology, pathology, physiology, molecular and developmental biology, and clinical medicine using sophisticated tools in genomics/proteomics/... genetics, genome editing, and bioengineering.The journal will consider submissions that address vascular cells in the context of:Atherosclerosis, thrombosis, hemostasisNeurovascu... diseasesDiabetes, obesity, and metabolic syndromePulmonary hypertensionCardiova... toxicity induced by anticancer drugsTransplant arteriopathyVascular aging, repair, and regenerationReperfus... injuryImmunological influence in vascular diseasesMicrovascula... dysfunctionPlease check the latest journal related topics and articles on our Twitter account @VasPharma.
    • International Journal of Antimicrobial Agents

      • ISSN: 0924-8579
      Official journal of the International Society of Antimicrobial ChemotherapyThe International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, etc.). In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents. Special attention is given to articles providing insight into the problems of antimicrobial resistance both in the hospital and in the community. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.Additional information on the ISAC and its activities can be found at the ISAC Web site at: https://www.isac.wor...
    • Currents in Pharmacy Teaching and Learning

      • ISSN: 1877-1297
      Currents in Pharmacy Teaching and Learning is devoted to dissemination of high quality, peer-reviewed scholarship relevant to all areas of pharmacy education—promoting educational research excellence. The Journal maintains a particular focus in two major areas: pharmacy faculty development in the scholarship of teaching and learning and the scholarship of interprofessional pharmacy education. With diverse editorial board members, authors, and peer reviewers, the Journal engages a variety of stakeholders in pharmacy education: educators, researchers, faculty practitioners, as well as interprofessional colleagues. Diverse author contributions are within original research, review articles, commentaries, and letters categories.Original research topics include, but are not limited to:Scholarship of Teaching and Learning: teaching/learning strategies; interprofessional educationQuality Improvement - assessment of programmatic/curricu... outcomesCurricular Revision – design, implementation, evaluationNew school/program strategiesAttitudes/... within pharmacy education
    • Pulmonary Pharmacology & Therapeutics

      • ISSN: 1094-5539
      Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.Research Areas Include:• All major diseases of the lung • Physiology • Pathology • Drug delivery • Metabolism • Pulmonary ToxicologyBefore submitting, please note the "Rules of 5" defining immediate rejection criteria of PPT:1. Out of scope: The paper should report on the use of pharmacological or toxicological studies (positive or negative) that are directly related to Pulmonary Pharmacology & Therapeutics.Immedia... rejection criteria are: a) Testing of extracts or plant parts that are not characterized b) Case Reports or n=1 studies2. Too preliminary: A paper must be based on a thorough and extensive study, using proper controlsImmediate rejection criteria are: a) In vitro studies with a single dose, or very high concentration b) Single dose studies with very few animals, no dose-response studies c) No proper controls. d) Repetition or confirmation of an earlier work3. Unethical: The study must have been carried under appropriate ethical approval for the study (either animal or human).4. Inappropriate experiments or lacking essential detailImmediate rejection criteria are: a) Wrong species or lacking details on the exact number of animals/subjects used b) No details of structure if a new drug is used for the first time5. Lack of novelty: The study must represent a novel approach to the field.Immediate rejection criteria are: a) Repetition of well known data b) No advance of knowledge in the fieldNote that only manuscripts written in good English will be considered by the Editors (British usage is preferred).
    • Contemporary Clinical Trials

      • ISSN: 1551-7144
      Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers not exceeding 4,000 words, short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/comment... on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.The following topics are covered in the journal:Unconvention... design features of specific trials and their rationalePreliminary or full results of clinical trials with unconventional design featuresStatistical methods for all aspects of clinical trialsMethodologies for clinical trial operations including trial management and optimization; patient recruitment and retention; and trial quality monitoring and assessmentData management methodologies including data collection; database maintenance; data quality assurance; safety monitoring and risk management; and patient registriesRegulatory requirements and their impact on clinical trialsEthical and legal considerations in clinical trialsRisk-benefit, cost-effectiveness and decision analyses in clinical trialsContemporary Clinical Trials is unique in that it is outside the confines of disease specifications, and it strives to adapt and grow with an expanding clinical trials landscape as the needs of clinical research evolve in today's dynamic healthcare environment.Having taken upon the important role as a platform for knowledge exchange between experts in different disciplines related to clinical trials, the ultimate goal of Contemporary Clinical Trials is to advance this field of research for the benefit of patients.We look forward to receiving your contribution! Authors are also welcome to submit to the journal's open access companion title, Contemporary Clinical Trials Communications .Benefits to authors Contemporary Clinical Trials also provides many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center